Study: antimicrobial peptide-coated contact lenses are safe

Article

A recent study published in Optometry and Vision Science supported the biocompatibility of contact lenses coated with an antimicrobial peptide, which could help lower the risk of contact lens-related infections.

Philadelphia-A recent study published in Optometry and Vision Science supported the biocompatibility of contact lenses coated with an antimicrobial peptide, which could help lower the risk of contact lens-related infections. 

The study, conducted at the University of New South Wales School of Optometry and Vision Science in Sydney, Australia, found that the melamine-coated contact lenses could be worn safely without any major side effects.

In addition to conducting testing on rabbits, a prospective, randomized, double-masked, one-day human clinical trial evaluated subjective responses and ocular physiology during contralateral wear of the melamine-coated and uncoated (control) lenses. Follow-up visits were conducted at one and four weeks to monitor delayed reactions.

The melamine-coated lenses produced no observed differences in wettability, surface deposition, lens-fitting centration, movement, tightness, and corneal coverage in comparison to the control lenses. There were no significant differences in bulbar, limbal, or palpebral redness or conjunctival staining, although mean corneal staining was higher for test lenses compared to the control lenses. There was also no significant difference in lens comfort, dryness, and awareness, and no delayed reactions were observed with the test lenses.

The melamine-coated lenses retained more than 1.5 log inhibition against Pseudomonas aeruginosa and Staphylococcus aureus

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Karen R. Hoffman, OD, speaks on her AOA 2025 poster, which details a case series on fitting patients with irregular cornea and astigmatism with Zenlens (Bausch + Lomb)
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
© 2025 MJH Life Sciences

All rights reserved.